- RecruitingPHASE3
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
This study is looking at a new medicine called Ribupatide for people living with obesity. It compares Ribupatide with another medicine, Semaglutide, and a dummy treatment, to see how well it helps with weight loss. We want to find out if Ribupatide is more effective and safe.
For: ObesityUnited States · Australia · Bulgaria - RecruitingPHASE3
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
This study is looking at a new medicine called KAI-9531. It aims to see if weekly injections of this medicine can help people who are overweight or obese, and have other health issues related to their weight, lose weight. We want to know if it's safe and effective.
For: Obesity · OverweightUnited States · Argentina · Australia - RecruitingPHASE3
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
This study is testing a new medicine, Ribupatide, for people who are overweight or have obesity and also have type 2 diabetes. It aims to see if Ribupatide helps with weight loss and improves blood sugar levels compared to a dummy medicine.
For: Obesity With Diabetes · Overweight With DiabetesUnited States · Argentina · Australia